An Overview on Chemical Features and Metabolism of Synthetic and Natural Product-Based Medicine for Combating COVID-19

Author:

Kamal Kant Arya Rajeshwar1,Kumar Sethiya Neeraj2,Bisht Dheeraj1,Rashid Mohmmad3,Kumar Deepak4,Singh Anita1,Gupta Rupa5,Singh Rana Vijay2

Affiliation:

1. Department of Pharmaceutical Sciences, Sir J. C. Bose Technical Campus Bhimtal, Kumaun University, Nainital, Uttarakhand, India - 263136.

2. Faculty of Pharmacy, DIT University, Dehradun, Uttarakhand, India - 248009.

3. Department of Pharmaceutical Chemistry and Pharmacognosy, College of Dentistry and Pharmacy, Buraydah Colleges, Al-Qassim, Saudi Arabia - 31717.

4. Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India

5. Department of Pharmacy, School of Health Sciences, Sushant University, Gurugram, Haryana, 122003, India.

Abstract

This review article covers the proposed synthetic and natural medicines, and their contribution in aspects of chemistry and metabolism for the management of COVID-19, which is still lacking in many published current studies. Most of the current studies were focused on physiology, epidemiology, and management of COVID-19. However, only a few of such studies mainly focussed on the chemistry of medicine in the management of the disease. In this contest, both natural and synthetic medicines, their synthesis and metabolism are highlighted in the current article. Currently, the entire world is struggling with the COVID-19 pandemic that has disturbed every aspect of life, caused by a newly discovered virus strain named severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). The outbreak continues to evolve, several research activities have been continuously carried out for understanding the origin, functions, treatments, and preventions of novel coronavirus (nCoV) infections such as SARS-CoV-2, SARS-CoV-1. There a lot of lines of treatment are being used all over the world but still, the perfect line of treatment for COVID-19 is not available. Various kinds of antiviral, anti-malarial, ACE inhibitors, and immunosuppressant drugs are being trialled worldwide for the management of COVID-19. A synthetic drug such as antimalarial drug (Hydroxychloroquine\Chloroquine), antiviral drug (Favipiravir, Remdesivir, Oseltamivir, EIDD-1931, Lopinavir, and Ritonavir), angiotensin-converting enzyme inhibitors/ angiotensin-receptor blockers (Captopril and Losartan), and immunosuppressant/arthritic drugs (Actemra, Baricitinib, Ruxolitinib, and Kevzara) for the management therapy for COVID-19 herewith complied to describe the chemical features and proposed metabolism process. Further, both chemistry and metabolism of proposed natural drug therapy such as quercetin, patchouli alcohol, baicalin, glycyrrhizic acid, and andrographolide for the management of COVID-19 infection are also included.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3